2023 | | Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study | 박준성 |
2023 | | Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation | 박준성 |
2023 | | The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma | 노진, 박준성, 정성현, 최윤석, 한재호 |
2022 | | Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study | 박준성 |
2022 | | Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined with Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma | 노진, 박준성, 정성현, 최윤석 |
2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
2021 | | Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca(2+) /calmodulin-mediated osteoclast differentiation | 박준성 |
2021 | | Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux | 김철호, 박준성, 정성현, 최용원 |
2020 | | Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia | 박준성 |
2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2020 | | Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | 노진, 박준성, 정성현, 한재호 |
2020 | | A membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsis | 박준성 |
2019 | | The comparison of Carfilzomib, and dexamethasone versus pomalidomide-based combination chemotherapy after a 2nd-line therapy in relapsed and refractory multiple myeloma patients | 박준성 |
2019 | | The role of surgical resection before palliative chemotherapy in advanced gastric cancer | 강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈 |
2018 | | 469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis | 강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2018 | | The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma | 박준성, 정성현 |
2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2018 | | Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma | 강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2018 | | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | 박준성 |
2018 | | Intracellular formyl peptide receptor regulates naive CD4 T cell migration | 박준성 |
2018 | | Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation | 박준성, 정성현 |
2018 | | The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2018 | | Pseudo-Chediak-Higashi granules in myeloid cells in therapy-related AML with RUNX1-RUNX1T1 | 박준성, 조성란 |
2018 | | Activation of formyl peptide receptor 2 by WKYMVm enhances emergency granulopoiesis through phospholipase C activity | 박준성 |
2018 | | The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia | 박준성, 조성란, 한재호 |
2017 | | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 박준성, 정성현 |
2017 | | Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia | 박준성 |
2017 | | Serum amyloid A inhibits dendritic cell differentiation by suppressing GM-CSF receptor expression and signaling | 박준성 |
2017 | | Phospholipase Cgamma1 suppresses foreign body giant cell formation by maintaining RUNX1 expression in macrophages | 박준성 |
2016 | | Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients | 박준성, 정성현 |
2016 | | Comparison of an international scale method and a log reduction method for monitoring of early molecular response in chronic myeloid leukemia patients | 박준성, 이위교, 임영애, 정성현, 조성란 |
2016 | | Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder | 박준성, 임현이, 정성현, 한재호 |
2016 | | Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF | 박준성 |
2016 | | Promotion of formyl peptide receptor 1-mediated neutrophil chemotactic migration by antimicrobial peptides isolated from the centipede Scolopendra subspinipes mutilans | 박준성 |
2016 | | Multicenter, prospective study to evaluate the efficacy of biweekly romiplostim administration in patients with immune thrombocytopenia | 박준성 |
2016 | | Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study | 박준성 |
2016 | | High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy | 강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2016 | | Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study | 박준성, 정성현 |
2015 | | A Case of Disseminated Trichosporon asahii Infection in an Immunocompromised Patient. | 박준성, 이은소 |
2015 | | Faggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia. | 박준성, 조성란, 최용원 |
2015 | | A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient. | 박준성, 조성란, 한재호 |
2015 | | Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2015 | | Serum amyloid A inhibits RANKL-induced osteoclast formation. | 박준성 |
2015 | | Antimicrobial peptide scolopendrasin VII, derived from the centipede Scolopendra subspinipes mutilans, stimulates macrophage chemotaxis via formyl peptide receptor 1. | 박준성 |
2015 | | Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea. | 박준성 |
2015 | | Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome. | 박준성 |
2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome? | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최용원, 최진혁, 한상욱, 한재호 |
2015 | | Stress-induced NF-κB activation differentiates promyelocytic leukemia cells to macrophages in response to all-trans-retinoic acid. | 박준성, 임인경 |
2014 | | Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter study | 박준성 |